HYPOKALEMIA BLUNTS LEFT VENTRICULAR MASS REGRESSION IN HYPERTENSIVE PATIENTS DURING LOSARTAN- OR ATENOLOL-BASED TREATMENT: THE LIFE ECHO-SUBSTUDY

被引:0
|
作者
Chinali, M. [1 ]
Aurigemma, G. P. [1 ]
Okin, P. M. [2 ]
Gerdts, E. [3 ]
Wachtell, K. [4 ]
Kjeldsen, S. E. [5 ]
Julius, S. [6 ]
Dalhof, B. [7 ]
de Simone, G. [8 ]
Devereux, R. B. [2 ]
机构
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Haukeland Hosp, N-5021 Bergen, Norway
[4] Rigshosp, DK-2100 Copenhagen, Denmark
[5] Univ Oslo, Oslo, Norway
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Sahlgrens Univ Hosp, Gothenburg, Sweden
[8] Federico II Univ Hosp, Naples, Italy
关键词
D O I
10.1097/01.hjh.0000379531.51584.03
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:E442 / E443
页数:3
相关论文
共 50 条
  • [1] Hypokalemia Blunts Left Ventricular Mass Regression in Hypertensive Patients During Losartan- or Atenolol-Based Treatment: The LIFE Echo-substudy
    Chinali, Marcello
    Aurigemma, Gerard P.
    Okin, Peter M.
    Gerdts, Eva
    Wachtell, Kristian
    Kjeldsen, Sverre E.
    Julius, Stevo
    Dahlof, Bjorn
    de Simone, Giovanni
    Devereux, Richard B.
    [J]. CIRCULATION, 2009, 120 (18) : S1089 - S1089
  • [2] Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy)
    Gerdts, Eva
    Bjornstad, Hans
    Devereux, Richard B.
    Lund-Johansen, Per
    Davidsen, Einar S.
    Omvik, Per
    [J]. BLOOD PRESSURE, 2006, 15 (04) : 220 - 226
  • [3] Impact of overweight and obesity on changes in left ventricular structure and function during losartan- or atenolol-based antihypertensive treatment (the LIFE study)
    Gerdts, Eva
    de Simone, Giovanni
    Wachtell, Kristian
    Boman, Kurt
    Nieminen, Markku S.
    [J]. CIRCULATION, 2006, 114 (18) : 774 - 774
  • [4] Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy
    Christensen, Marina K.
    Olsen, Michael H.
    Wachtell, Kristian
    Tuxen, Christian
    Fossum, Eigil
    Bang, Lia E.
    Wiinberg, Niels
    Devereux, Richard B.
    Kjeldsen, Sverre E.
    Hildebrandt, Per
    Rokkedal, Jens
    Ibsen, Hans
    [J]. BLOOD PRESSURE, 2006, 15 (04) : 198 - 206
  • [5] Contrasting Hemodynamic Mechanisms of Losartan- vs. Atenolol-Based Antihypertensive Treatment: A LIFE Study
    Greve, Anders M.
    Olsen, Michael H.
    Bella, Jonathan N.
    Lonnebakken, Mai T.
    Gerdts, Eva
    Okin, Peter M.
    Palmieri, Vittorio
    Boman, Kurt
    Nieminen, Markku S.
    Omvik, Per
    Dahlof, Bjorn
    Devereux, Richard B.
    Wachtell, Kristian
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (09) : 1017 - 1023
  • [6] The effect of losartan versus atenolol on hemostasis and fibrinolysis in hypertensive patients with left ventricular hypertrophy: A LIFE substudy
    Boman, KO
    Olsen, MH
    Wachtell, K
    Olofsson, M
    Ibsen, H
    Dige-Petersen, H
    Nilsson, TK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 482A - 482A
  • [7] LOSARTAN (L) BUT NOT ATENOLOL (A) REDUCES AN INDEX OF CARDIAC FIBROSIS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY (LVH): A LIFE SUBSTUDY
    Ciulla, M. M.
    Paliotti, R.
    Esposito, A.
    Acquistapace, G.
    Magrini, F.
    Devereux, R.
    Zanchetti, A.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E352 - E353
  • [8] Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study)
    Gerdts, E
    Roman, MJ
    Palmieri, V
    Wachtell, K
    Smith, G
    Nieminen, MS
    Dahlöf, B
    Devereux, RB
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (06) : 417 - 422
  • [9] Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study)
    E Gerdts
    M J Roman
    V Palmieri
    K Wachtell
    G Smith
    M S Nieminen
    B Dahlöf
    R B Devereux
    [J]. Journal of Human Hypertension, 2004, 18 : 417 - 422
  • [10] Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial
    Devereux, RB
    Dahlöf, B
    Gerdts, E
    Boman, K
    Nieminen, MS
    Papademetriou, V
    Rokkedal, J
    Harris, KE
    Edelman, JM
    Wachtell, K
    [J]. CIRCULATION, 2004, 110 (11) : 1456 - 1462